Abstract:Background Polygenic risk scores (PRS) have ushered in a new era in genetic epidemiology, offering insights into individual predispositions to a wide range of diseases. However, despite recent marked enhancements in their predictive power, there are still challenges that need to be overcome before PRS-based models can be broadly applied in the clinic, including sufficient accuracy, easy interpretability and portability across diverse populations. Methods Leveraging trans-ancestry genome-wide association study (GWAS) meta-analysis, we generated novel, diverse summary statistics for 30 medically-related traits which were used to benchmark the performance of six existing PRS algorithms using UK biobank. Observing that SBayesRC had the best overall performance but recognizing strengths in each method, we developed an ensemble PRS model using logistic regression to combine outputs from top-performing algorithms. This ensemble model was validated on the diverse eMERGE and PAGE MEC cohorts, and the performance was compared against current state-of-the-art PRS models. To enhance predictive accuracy for clinical application, we incorporated easily-accessible clinical characteristics such as age, gender, ancestry and risk factors, creating disease prediction models intended as prospective diagnostic tests, with easily interpretable positive or negative outcomes. Results Predictive performance of PRS models improved with trans-ancestry GWAS meta-analysis and was further enhanced by the ensemble model, which surpassed state-of-art PRS models. When applied to external cohorts, performance drops were minimal, indicating good calibration. After adding clinical characteristics, 12 out of 30 models surpassed 80% AUC. Further, 25 traits exceeded the diagnostic odds ratio (DOR) of 5 and 19 traits exceeded DOR of 10 for all ancestry groups, indicating high predictive value. The highest DOR in a population with a sufficient number of cases was 66.2 for Alzheimer's disease in Europeans. Our PRS model for coronary artery disease identified 55-80 times more true coronary events than rare pathogenic variant models, reinforcing its clinical potential. The polygenic component modulated the effect of high-risk rare variants, stressing the need to consider all genetic components in clinical settings. Conclusions Newly developed PRS-based disease prediction models have sufficient accuracy and portability to warrant consideration of being used in the clinic.

Using Pre-training and Interaction Modeling for ancestry-specific disease prediction in UK Biobank

A comprehensive investigation of statistical and machine learning approaches for predicting complex human diseases on genomic variants

Improving GWAS discovery and genomic prediction accuracy in biobank data

Machine Learning Strategies for Improved Phenotype Prediction in Underrepresented Populations

Optimization of Multi-Ancestry Polygenic Risk Score Disease Prediction Models

All of Us diversity and scale improve polygenic prediction contextually with greatest improvements for under-represented populations

Integrative machine learning approaches for predicting disease risk using multi-omics data from the UK Biobank

Improving GWAS performance in underrepresented groups by appropriate modeling of genetics, environment, and sociocultural factors

Genomic Prediction of Complex Disease Risk

A Non-Parametric Method for Building Predictive Genetic Tests on High-Dimensional Data

Machine Learning Prediction of Biomarkers from SNPs and of Disease Risk from Biomarkers in the UK Biobank

Leveraging functional genomic annotations and genome coverage to improve polygenic prediction of complex traits within and between ancestries

Incorporating functional priors improves polygenic prediction accuracy in UK Biobank and 23andMe data sets

Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data

Analyses of biomarker traits in diverse UK biobank participants identify associations missed by European-centric analysis strategies

Improved polygenic prediction by Bayesian multiple regression on summary statistics

Disease prediction with multi-omics and biomarkers empowers case-control genetic discoveries in the UK Biobank

Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank

SPLENDID incorporates continuous genetic ancestry in biobank-scale data to improve polygenic risk prediction across diverse populations

JointPRS: A Data-Adaptive Framework for Multi-Population Genetic Risk Prediction Incorporating Genetic Correlation

Optimizing clinico-genomic disease prediction across ancestries: a machine learning strategy with Pareto improvement